TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 2 | 1 | 4 | 8 | 3 | 1 | 32 | 125 | 184 | 59 |
| P | %wins | 100 | 75 | 75 | 75 | 75 | 67 | 78 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/15/14 18:54 | 12/11/14 | RVNC | Revance Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Silvernail Lauren P | CA | O | CFO,Secr | P | 17 | 17.74 | 3 | 1 | 7 | 16 | D | -41 | -15 | -13 | 6 | 2 | -4 | 1 | 8 | 4 | 15 | 97 | 114 | ||
8/15/11 16:51 | 8/11/11 | ISTA | Ista Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Silvernail Lauren P | CA | O | CFO | P | 11 | 4.28 | 3 | 3 | 3 | 97 | D | -20 | 30 | -43 | -58 | -44 | -44 | -10 | -10 | 6 | -6 | -17 | -19 | 82 | |
12/11/08 15:52 | 12/9/08 | ISTA | Ista Pharmaceuticals Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Silvernail Lauren P | CA | O | CFO | P | 11 | 0.6293 | 0 | 17 | 65 | 43 | D | -88 | -86 | -64 | -46 | 8 | 84 | 30 | 34 | 21 | 1 | 15 | 128 | 338 | 463 |
5/12/05 18:10 | 5/12/05 | ISTA | Ista Pharmaceuticals Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Silvernail Lauren P | CA | O | CFO | P.d | 38 | 7.54 | 1 | 5 | New | 5 | D | 87 | -47 | -25 | -26 | -23 | -4 | -1 | -4 | 2 | 10 | 1 | 4 | -18 | -26 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |